The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 13, 2015
Filed:
Oct. 17, 2013
Applicant:
Signal Pharmaceuticals, Llc, San Diego, CA (US);
Inventors:
Weiming Xu, San Diego, CA (US);
Deborah Mortensen, San Diego, CA (US);
Shuichan Xu, San Diego, CA (US);
Kimberly Elizabeth Fultz, San Diego, CA (US);
Assignee:
Signal Pharmaceuticals, LLC, San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4985 (2006.01); G01N 33/574 (2006.01); G01N 33/50 (2006.01); C12Q 1/48 (2006.01); A61K 31/437 (2006.01); A61K 31/519 (2006.01); A61K 31/522 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4985 (2013.01); A61K 31/437 (2013.01); A61K 31/519 (2013.01); A61K 31/522 (2013.01); C12Q 1/485 (2013.01); G01N 33/5011 (2013.01); G01N 2333/9121 (2013.01); G01N 2800/52 (2013.01);
Abstract
Provided herein are methods for treating a cancer treatable by inhibition of phosphorylation of PRAS40, GSK3β or p70S6K1, comprising administering an effective amount of a TOR kinase inhibitor to a patient having a cancer treatable by inhibition of phosphorylation of PRAS40, GSK3β or p70S6K1.